(Reuters) - The U.S. Food and Drug Administration on Tuesday rejected Prevention Bio Inc.'s approval of the experimental diabetes drug teplizumab, citing insufficient data,...
The research analysis report on the Global Virtual / online fitness market examines historical data and new technologies to identify the main drivers influencing...